miR-506, which is often downregulated in breast cancer, was reported to target the 3′UTR of IQGAP1 and impact cell proliferation, invasion, and adhesion, possibly through the RAS-MAPK pathway [123]. This evidence concerns the gene IQGAP1 and breast cancer.